Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Resverlogix to Present at the Clinical Trials on Alzheimer's Disease Congress 2019
Those are some pretty strong statements. First sub-title of news release is:
"Apabetalone treatment improves cognition in CVD patients with diabetes"
Then, they quote Dr. Cummings:
"The effects seen in the BETonMACE trial for those with cognitive impairment are very promising and suggest that epigenetic modulators such as apabetalone may represent an important and novel approach to treatment of cognitive disorders"
